1Riedemann NC,Guo RF,Ward PA. The enigma of sepsis. J Clin Invest, 2003,112:460-467.
2Dellinger RP, Cadet JM, Masur H, et al. Surviving sepsis campaign gnidelines for management of severe sepsis and septic shock. Crit Care Med, 2004,32:858-873.
3Dellinger RP Levv MM,Carlet JM,et al. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock, 2008. Intensive Care Med,2008,34 : 17-60.
4Bone RC ,Balk RA ,Cerra FB,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992,101 : 1644-1655.
5Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ ATS/SIS International sepsis definition conference. Crit Care Med, 2003,32 : 1250 -1256.
6Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference:definitions for sepsis and organ dysfunction in pediatrics.Crit Care Med ,2005 ,6 :2-8.
9Sunden-Cullberg J, Norr-by-Teglund A, Rouhiainen A, et al. Persistent elevation of high mobility group box-1 protein ( HMGB1 ) in patients with severe sepsis and septic shock. Crit Care Med,2005 ,33 :564-573.
10Ulloa L,Ochani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA ,2002,99 : 12351-12356.
二级参考文献47
1Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science, 1999, 285: 248-251.
2Su GL, Freeswick PD, Geller DA, et al. Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. Evidence for extrahepatic expression. J Immunol, 1994, 153: 743-752.
3Galea E, Reis DJ, Fox ES, et al. CD14 mediates endotoxin induction of nitric oxide synthase in cultured brain glial cells. J Neuroimmunol, 1996, 64: 19-28.
4Fang WH, Yao YM, Shi ZG, et al. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury. Shock, 2002, 17: 329-333.
5Kitchens RL. Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol, 2000, 74:61-82.
6Fang WH, Yao YM, Shi ZG, et al. Effect of recombinant bactericidal/ permeability-increasing protein on endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression in rats after thermal injury. Crit Care Med, 2001, 29: 1452-1459.
7Gazzano-Santoro H, Meszaros K, Birr C, et al. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infect Immun, 1994, 62:1185-1191.
8Wilkinson JD, Pollack MM, Glass NL, et al. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr ,1987, 111:324-328.
9Leteurtre S, Martinot A, Duhamel A, et al. Development of a pediatric multiple organ dysfunction score: use of two strategies.Medical Decision Making,1999, 19:399-410.
10Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective,observational, muhicentre study. Lancet, 2003,362 : 192-197.
6Bersten AD,Edibam C,Hunt T,et al.Incidence and mortality of acute lung injury and the acute respiratory distress distress syndrome in three Australian states[J].Am J Respir Crit Care Med,2002,165(4):443-448.
7Chaudry IH,Wichterman KA,Baue AE.Effect of sepsis on tissue adenine nucleotide levelas[J].Surgery,1979,85(2):205-211.
8Nolan A,Kobayashi H,Naveed B,et al.Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis[J].PLo S ONE,2009,4(8):e6600.
